Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Fermi Inc ...

U.S. IND represents the second regulatory clearance for KLN-1010 and enables the first multi-center clinical trial in the U.S ...

Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...

Novotech, a globally recognized full-service biotech clinical research organization (CRO), is pleased to announce the appointment of Dr. Anand Tharmaratnam as its new Chief Executive Officer.Dr.

Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...

Service expansions accelerate pharmacy’s achievement of 2 million shipments while maintaining industry-leading patient ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2025 ...

Approximately 60% of women will experience a UTI in their lifetime2 — Flush Advanced+ helps to reduce the risk of recurrent ...

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

Merck (known as MSD outside of the United States and Canada) will complete its $9.2 billion acquisition of Cidara ...

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire ...

Vygon, a leading group specialized in the design, manufacturing and marketing of medical devices in neonatology and vascular ...